These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 4623679)

  • 1. An ergot alkaloid preparation (hydergine) in geriatric therapy.
    Roubicek J; Geiger C; Abt K
    J Am Geriatr Soc; 1972 May; 20(5):222-9. PubMed ID: 4623679
    [No Abstract]   [Full Text] [Related]  

  • 2. An ergot preparation (hydergine) in the treatment of cerebrovascular disorders in the geriatric patient: double-blind study.
    Ditch M; Kelly FJ; Resnick O
    J Am Geriatr Soc; 1971 Mar; 19(3):208-17. PubMed ID: 4998602
    [No Abstract]   [Full Text] [Related]  

  • 3. An ergot alkaloid preparation (Hydergine) in the treatment of dementia: critical review of the clinical literature.
    Hughes JR; Williams JG; Currier RD
    J Am Geriatr Soc; 1976 Nov; 24(11):490-7. PubMed ID: 823192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Electroencephalographic alterations after administration of vaso-active substance (Hydergine)].
    Pires de Oliveira RS
    Arq Neuropsiquiatr; 1973 Jun; 31(2):107-22. PubMed ID: 4198581
    [No Abstract]   [Full Text] [Related]  

  • 5. An ergot alkaloid preparation (Hydergine) versus papaverine in treating common complaints of the aged: double-blind study.
    Bazo AJ
    J Am Geriatr Soc; 1973 Feb; 21(2):63-71. PubMed ID: 4631704
    [No Abstract]   [Full Text] [Related]  

  • 6. An ergot alkaloid preparation (hydergine) versus placebo for treatment of symptoms of cerebrovascular insufficiency: double-blind study.
    Jennings WG
    J Am Geriatr Soc; 1972 Aug; 20(8):407-12. PubMed ID: 4626496
    [No Abstract]   [Full Text] [Related]  

  • 7. A double-blind investigation of hydergine in the treatment of cerebrovascular insufficiency in the elderly.
    Rao DB; Norris JR
    Johns Hopkins Med J; 1972 May; 130(5):317-24. PubMed ID: 4622959
    [No Abstract]   [Full Text] [Related]  

  • 8. An ergot preparation (Hydergine) for relief of symptoms of cerebrovascular insufficiency.
    Banen DM
    J Am Geriatr Soc; 1972 Jan; 20(1):22-4. PubMed ID: 4628906
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of an ergot preparation (hydergine) in the convalescent phase of stroke.
    Bochner F; Eadie MJ; Tyrer JH
    J Am Geriatr Soc; 1973 Jan; 21(1):10-7. PubMed ID: 4630036
    [No Abstract]   [Full Text] [Related]  

  • 10. Two trials comparing 'Hydergine' with placebo in the treatment of patients suffering from cerebrovascular insufficiency.
    Rehman SA
    Curr Med Res Opin; 1973; 1(8):456-62. PubMed ID: 4204089
    [No Abstract]   [Full Text] [Related]  

  • 11. An ergot alkaloid preparation (Hydergine) in the treatment of presenile brain atrophy (Alzheimer's disease): case report.
    Burian E
    J Am Geriatr Soc; 1974 Mar; 22(3):126-8. PubMed ID: 4204771
    [No Abstract]   [Full Text] [Related]  

  • 12. Dihydrogenated ergot alkaloids (Hydergine) and cerebrovascular insufficiency.
    Med Lett Drugs Ther; 1970 Mar; 12(6):27-8. PubMed ID: 4994841
    [No Abstract]   [Full Text] [Related]  

  • 13. A clinical trial comparing 'Hydergine' with placebo in the treatment of cerebrovascular insufficiency in elderly patients.
    McConnachie RW
    Curr Med Res Opin; 1973; 1(8):463-8. PubMed ID: 4204090
    [No Abstract]   [Full Text] [Related]  

  • 14. [CLINICAL EVLUATION OF HYDERGINE IN GERIATRIC THERAPY].
    SOPRANA M; FRANZONI A
    Minerva Med; 1965 Jun; 56():2220-6. PubMed ID: 14341447
    [No Abstract]   [Full Text] [Related]  

  • 15. Symptomatic treatment of cerebrovascular insufficiency with hydergine.
    Gerin J
    Curr Ther Res Clin Exp; 1969 Sep; 11(9):539-46. PubMed ID: 4980884
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical examination of a combined antihypersensitive agent containing hydrogenated ergot alkaloid].
    Wanner J
    Schweiz Med Wochenschr; 1968 Aug; 98(32):1196-201. PubMed ID: 4974016
    [No Abstract]   [Full Text] [Related]  

  • 17. [Double blind test of hydergine in the aged].
    Bargheon J
    Nouv Presse Med; 1973 Sep; 2(31):2053-5. PubMed ID: 4199834
    [No Abstract]   [Full Text] [Related]  

  • 18. The hydrogenated alkaloids of ergot (hydergine) in geriatrics; follow-up study.
    POPKIN RJ
    Am Pract Dig Treat; 1956 Oct; 7(10):1594-7. PubMed ID: 13362833
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hydergine in the symptomatic treatment of cerebrovascular insufficiency. Comparative clinical test with a placebo].
    Teixeira JE
    Hospital (Rio J); 1970 Jun; 77(6):1907-31. PubMed ID: 4992010
    [No Abstract]   [Full Text] [Related]  

  • 20. [Letter: Double blind study of hydergine in aged patients].
    Paux G; Boismare F; Delaunay P
    Nouv Presse Med; 1975 Oct; 4(35):2529. PubMed ID: 812060
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.